ChemoMetec has an incredible growth track record, high profit margins and incredibly low customer churn. Find out why this company has >50% EBITDA margins, ROIC >50% and >30% organic growth!
Thank you! I agree on the fundamentals. Unfortunately not the right price, but the opportunity might come. In the meantime, I am happy to follow the company and its end markets.
Excellent analysis. Great company and future, but price is the last variable in the equation.
Good to have it in the radar if markets give it an opportunity to jump in
Thank you! I agree on the fundamentals. Unfortunately not the right price, but the opportunity might come. In the meantime, I am happy to follow the company and its end markets.
sept 23: stock price 326 DKK ... building up position now?
Any thoughts after the huge price correction and the CEO leaving?
Would you like to write an update after report yesterday?